LEUKOTAC
LIVE

Serial Number

87849391

Owner

ELSALYS BIOTECH

Attorney

Michelle P. Ciotola

Filing Date

Mar 26, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LEUKOTAC Trademark

Serial Number: 87849391 • Registration: 6115761

LEUKOTAC is a trademark filed by ELSALYS BIOTECH on March 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ELSALYS BIOTECH

LYON 69007 , FR

Entity Type: 99

MEDIOLANUM FARMACEUTICI S.p.A. (19 trademarks)

VIA S.G. Cottolengo 15/31
20143 Milano , IT

Entity Type: 99

Trademark Details

Filing Date

March 26, 2018

Registration Date

August 4, 2020

Published for Opposition

May 19, 2020

Goods & Services

Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; biotechnological preparations for medical and veterinary use, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases

Medical services; pharmaceutical advice

Research and consultancy in the field of biotechnology; research and development in the field of biotechnology; scientific and technical consultation, namely, engineering evaluations and appraisals in the fields of science and technology; scientific and technology research in the field of immuno-oncology and autoimmune disease; laboratory research and analysis services in the field of immuno-oncology and autoimmune disease; scientific chemistry, biology and biotechnology laboratories; scientific laboratory services; laboratory testing, research and development of new products for others; conducting clinical trials for others in the field of medicines, molecules and medical devices; medical laboratory analysis services relating to the treatment of persons; medical laboratory services, including sample analysis; medical laboratory analysis services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 4, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 24, 2024 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 10, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 3, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 3, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 3, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 24, 2020 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2020 COAR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 28, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 28, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 28, 2019 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 28, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 28, 2019 GNSL
SUSPENSION LETTER WRITTEN
Feb 28, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2019 CRFA
ASSIGNED TO LIE
Jan 17, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 14, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2018 NWOS
NEW APPLICATION ENTERED
Mar 29, 2018 NWAP